China International Exhibition on Pharmaceutical Raw Materials

June 16–18, 2026, the 24th edition of CPHI China 2026 was successfully held at the Shanghai New International Expo Center. This flagship event of the Asian pharmaceutical industry, with an exhibition space exceeding 250,000 square meters, attracted more than 3,701 exhibitors from home and abroad, as well as 119,172 professional visitors hailing from 168 countries and regions, once again underscoring the robust global connectivity of China’s pharmaceutical sector.

This year’s show set a new record in scale, occupying the entire Shanghai New International Expo Center. The exhibit lineup spanned the entire pharmaceutical value chain, including APIs, excipients, finished dosage forms, contract R&D and manufacturing, natural extracts, biopharmaceuticals, pharmaceutical machinery and packaging equipment, laboratory instruments, and environmental and cleanroom solutions. Over the three-day event, lively business discussions echoed throughout the venue, with bustling crowds at every booth, facilitating deep connections between international buyers and exhibiting companies, and fostering a vibrant trade atmosphere. Many exhibitors reported high-quality leads, abundant order intentions, and a noticeable resurgence of overseas buyers, resulting in outcomes that exceeded expectations.

In terms of internationalization, CPHI China 2026 demonstrated strong global appeal. Among the professional visitors from 168 countries and regions, there was a marked increase in buyers from emerging markets such as Southeast Asia, the Middle East, and Latin America, while the quality of buyers from traditional European and North American markets continued to improve. During the event, numerous bilateral matchmaking sessions and international trade‑matching activities were held concurrently, effectively advancing the deep integration and collaborative development of the global pharmaceutical supply chain. The exhibition served not only as a platform for product showcasing but also as a vital hub for global pharmaceutical trade and cooperation.

Alongside the exhibition, more than one hundred high‑profile industry conferences and technical forums were organized, bringing together nearly a thousand industry experts, corporate leaders, and pioneering researchers in Shanghai. These events delved into key topics such as global pharmaceutical policy trends, innovative R&D pathways, smart manufacturing upgrades, and green, sustainable development. Covering everything from APIs to finished dosage forms, from R&D to production, and from domestic market strategies to global expansion, the forum agenda addressed pressing issues across the entire value chain, providing attendees with cutting-edge insights and strategic guidance.

CPHI China remains committed to building an integrated industrial service platform that combines product display, knowledge exchange, and collaborative opportunities. During this edition, the organizers enhanced their online business‑matching system, dedicated new‑product launch zones, and innovative product showcase walls, creating efficient and precise channels for connecting exhibitors and buyers. The optimization and upgrading of the pre‑registration system and on‑site demand‑matching services further improved the effectiveness of supplier–buyer interactions, earning high praise from both exhibitors and visitors.

Looking back on CPHI China’s 24-year journey, the exhibition has evolved from its origins as a platform for exporting active pharmaceutical ingredients into an industry benchmark that spans the entire value chain and connects global resources. Meanwhile, China’s pharmaceutical sector is accelerating its transformation from a “global manufacturing hub” to a “source of indigenous innovation.” Throughout this process, CPHI China has consistently served as a vital bridge and platform.